Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01269190 · ClinicalTrials.gov registry record · NA

Wide-Field and High Resolution In Vivo Imaging in Visualizing Lesions in Patients With Oral Neoplasia Undergoing Surgery

A NA study of Oral Cavity Neoplasm, sponsored by M.D. Anderson Cancer Center.

Recruiting
Registry status
NA
Development phase
275
Enrollment target
1
Study location

NCT01269190 is a NA study of Oral Cavity Neoplasm that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 275 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01269190, a NA study of Oral Cavity Neoplasm, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.

RECRUITING
Registry status
NA
Development phase
275 participants
Enrollment target
1
Study location

Study Summary

This clinical trial studies wide-field and high resolution in vivo imaging in visualizing lesions in patients with abnormal or uncontrolled oral cell growth (neoplasia) undergoing surgery. Diagnostic procedures, such as wide-field and high resolution in vivo imaging, are devices that let researchers look at a wide area of the lining of the mouth by shining different colors inside the mouth and taking pictures and this may help doctors to decide if a mouth lesion has a high risk of being pre-cancerous or cancerous.

Conditions Studied

Interventions

  • PROCEDURE High-Resolution Microendoscopy
  • PROCEDURE Multispectral Imaging
  • DRUG Proflavine

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 275 participants
Start Date 2010-12-30
Est. Completion 2028-12-31
Phase NA

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT01269190

The ClinicalTrials.gov registry entry for NCT01269190 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 275 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Oral Cavity Neoplasm appearing as the primary indexed condition, and to 3 interventions - of which High-Resolution Microendoscopy is the first listed.

NCT01269190 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT01269190 about?

NCT01269190 is a clinical study titled "Wide-Field and High Resolution In Vivo Imaging in Visualizing Lesions in Patients With Oral Neoplasia Undergoing Surgery". This clinical trial studies wide-field and high resolution in vivo imaging in visualizing lesions in patients with abnormal or uncontrolled oral cell growth (neoplasia) undergoing surgery. Diagnostic procedures, such as wide-field and high resolution in vivo imaging, are devices that let researchers...

What is the current status of trial NCT01269190?

This trial is currently recruiting. It is a NA study. The enrollment target is 275 participants. The study started on 2010-12-30. Estimated completion is 2028-12-31.

What conditions does trial NCT01269190 study?

This clinical trial studies the following conditions: Oral Cavity Neoplasm.

What interventions are being tested in trial NCT01269190?

The interventions under investigation include: High-Resolution Microendoscopy (PROCEDURE), Multispectral Imaging (PROCEDURE), Proflavine (DRUG).

Who is sponsoring clinical trial NCT01269190?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01269190 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.